February 2026 UPMC for You and UPMC Community HealthChoices formulary update

Feb. 2026Pharmacy Updates

Pulmicort Flexhaler has a new distributor, Rubicon Holding. National Drug Codes (NDCs) for Pulmicort Flexhaler from Rubicon Holding are not included in the Medicaid Drug Rebate program and are not covered under the Medicaid Prescription Drug Program. Pulmicort Flexhaler NDCs from the previous manufacturer, H2 Pharma, have been discontinued but may be billed/dispensed until supplies are exhausted. 

To avoid denials at the pharmacy, prescribers are encouraged to begin transitioning current Pulmicort Flexhaler patients to covered alternatives as soon as possible.

Preferred/Covered PDL alternatives for Pulmicort Flexhaler include the following*:

  • Arnuity Ellipta
  • Asmanex HFA
  • Asmanex Twisthaler
  • Budesonide 0.25 mg/2 mL and 0.5 mg/2 mL Respules
  • Qvar Redihaler
  • Fluticasone Propionate HFA for patients < 19 years old

Recent Announcements

Medicaid Renewal

Starting in 2027, some Medicaid recipients (ages 19–-64) will have new requirements to keep their coverage.
Aug. 2026Important Notices

Provider Directory Updates and Required Attestation

As you know, UPMC Health Plan requires all providers to verify their provider directory information at least every 90 days (quarterly).
Aug. 2026Important Notices

Voluntary nationwide recall: Tyenne (Fresenius – August 2026)

Fresenius Kabi is recalling one lot, lot 16UI07, of Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL (20 mg/mL) 20 mL vials. Tyenne is used for the treatment of certain arthritis conditions.
Aug. 2026Pharmacy Updates